Show simple item record

dc.contributor.authorLam, Thomas B L
dc.contributor.authorMacLennan, Steven
dc.contributor.authorWillemse, Peter-Paul M.
dc.contributor.authorMason, Malcolm D.
dc.contributor.authorPlass, Karin
dc.contributor.authorShepherd, Robert
dc.date.accessioned2020-10-02T23:04:42Z
dc.date.available2020-10-02T23:04:42Z
dc.date.issued2019-12-01
dc.identifier147241110
dc.identifierc4116266-2117-4b66-b11e-9ab4186003d5
dc.identifier85072774547
dc.identifier31587989
dc.identifier000496915900015
dc.identifier.citationLam , T B L , MacLennan , S , Willemse , P-P M , Mason , M D , Plass , K & Shepherd , R 2019 , ' EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study) ' , European Urology , vol. 76 , no. 6 , pp. 790-813 . https://doi.org/10.1016/j.eururo.2019.09.020en
dc.identifier.issn0302-2838
dc.identifier.otherORCID: /0000-0002-2691-8421/work/63244102
dc.identifier.otherMendeley: 6fdf58bf-a8a4-3e7c-a8db-2b27b4acb928
dc.identifier.urihttps://hdl.handle.net/2164/15196
dc.descriptionThe authors are grateful to the following individuals and organisations for the following contributions: R. Bryan Rumble, MSc for reviewing and commenting on the manuscript; American Society of Clinical Oncology (ASCO) for providing members who participated in the survey and consensus group meeting; IPSEN for providing an unrestricted educational grant; however IPSEN did not have any access to the study data nor did they have any control over the final manuscript; European Association of Urology (EAU) for providing an unrestricted educational grant; however the EAU did not have any access to the data nor did they have any control over the final manuscript.en
dc.format.extent24
dc.format.extent328102
dc.format.extent775970
dc.language.isoeng
dc.relation.ispartofEuropean Urologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectDeferred treatment with curative intenten
dc.subjectActive surveillance and monitoringen
dc.subjectLocalised prostate canceren
dc.subjectEligibilityen
dc.subjectFollow-upen
dc.subjectReclassificationen
dc.subjectOutcome measuresen
dc.subjectConsensus statementsen
dc.subjectDelphi surveyen
dc.subjectConsensus group meetingen
dc.subjectClinical practice guidelinesen
dc.subjectR Medicineen
dc.subjectUrologyen
dc.subject.lccRen
dc.titleEAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study)en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1016/j.eururo.2019.09.020
dc.date.embargoedUntil2020-10-03
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85072774547&partnerID=8YFLogxKen
dc.identifier.vol76en
dc.identifier.iss6en


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record